Evidence map›Paper›PMID 19843520›Full record

ArticleThe Journal of biological chemistry2009

Beta integrin tyrosine phosphorylation is a conserved mechanism for regulating talin-induced integrin activation.

Nicholas J Anthis, Jacob R Haling, Camilla L Oxley, Massimiliano Memo, Kate L Wegener, Chinten J Lim, Mark H Ginsberg, Iain D Campbell

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 127 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Adhesion ofFrontiers in cell and developmental biology · 2022
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Nicholas J AnthisDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3DR, United Kingdom, California 92093. Electronic address: nick.anthis@gmail.com.
Jacob R HalingDepartment of Medicine, University of California, San Diego, La Jolla, California 92093.
Camilla L OxleyDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3DR, United Kingdom, California 92093.
Massimiliano MemoDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3DR, United Kingdom, California 92093.
Kate L WegenerDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3DR, United Kingdom, California 92093.
Chinten J LimDepartment of Medicine, University of California, San Diego, La Jolla, California 92093.
Mark H GinsbergDepartment of Medicine, University of California, San Diego, La Jolla, California 92093.
Iain D CampbellDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3DR, United Kingdom, California 92093. Electronic address: iain.campbell@bioch.ox.ac.uk.
University of Oxford · GBUniversity of California, San Diego · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

Integrins are large membrane-spanning receptors fundamental to cell adhesion and migration. Integrin adhesiveness for the extracellular matrix is activated by the cytoskeletal protein talin via direct binding of its phosphotyrosine-binding-like F3 domain to the cytoplasmic tail of the beta integrin subunit. The phosphotyrosine-binding domain of the signaling protein Dok1, on the other hand, has an inactivating effect on integrins, a phenomenon that is modulated by integrin tyrosine phosphorylation. Using full-length tyrosine-phosphorylated (15)N-labeled beta3, beta1A, and beta7 integrin tails and an NMR-based protein-protein interaction assay, we show that talin1 binds to the NPXY motif and the membrane-proximal portion of beta3, beta1A, and beta7 tails, and that the affinity of this interaction is decreased by integrin tyrosine phosphorylation. Dok1 only interacts weakly with unphosphorylated tails, but its affinity is greatly increased by integrin tyrosine phosphorylation. The Dok1 interaction remains restricted to the integrin NPXY region, thus phosphorylation inhibits integrin activation by increasing the affinity of beta integrin tails for a talin competitor that does not form activating membrane-proximal interactions with the integrin. Key residues governing these specificities were identified by detailed structural analysis, and talin1 was engineered to bind preferentially to phosphorylated integrins by introducing the mutation D372R. As predicted, this mutation affects talin1 localization in live cells in an integrin phosphorylation-specific manner. Together, these results indicate that tyrosine phosphorylation is a common mechanism for regulating integrin activation, despite subtle differences in how these integrins interact with their binding proteins.

Indexed as

Amino Acid MotifsAmino Acid SubstitutionAnimalsCell LineDNA-Binding ProteinsIntegrin beta ChainsMiceMutation, MissenseNuclear Magnetic Resonance, BiomolecularPhosphoproteinsPhosphorylationProtein BindingProtein Structure, TertiaryRNA-Binding ProteinsTalinTyrosineDNA-Binding ProteinsDok1 protein, mouseIntegrin beta ChainsPhosphoproteinsRNA-Binding ProteinsTalinTln1 protein, mouseTyrosine

Identifiers

PMID19843520
PMCPMC2794784
OpenAlexW2059778210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.